Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5X21

Crystal structure of Thermus thermophilus transcription initiation complex with GpA and pseudouridimycin (PUM)

5X21 の概要
エントリーDOI10.2210/pdb5x21/pdb
関連するPDBエントリー5x22
分子名称DNA-directed RNA polymerase subunit alpha, ZINC ION, (1S)-1,4-anhydro-5-[(N-carbamimidoylglycyl-N~2~-hydroxy-L-glutaminyl)amino]-5-deoxy-1-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-D-ribitol, ... (12 entities in total)
機能のキーワードtranscription, rna polymerase, transcription inhibition, nucleoside-analog inhibitor, pseudouridimycin, transferase-dna complex, transferase/dna
由来する生物種Thermus thermophilus
詳細
細胞内の位置Cytoplasm : Q72L95
タンパク質・核酸の鎖数9
化学式量合計445097.09
構造登録者
Zhang, Y.,Ebright, R. (登録日: 2017-01-29, 公開日: 2017-07-05, 最終更新日: 2024-11-20)
主引用文献Maffioli, S.I.,Zhang, Y.,Degen, D.,Carzaniga, T.,Del Gatto, G.,Serina, S.,Monciardini, P.,Mazzetti, C.,Guglierame, P.,Candiani, G.,Chiriac, A.I.,Facchetti, G.,Kaltofen, P.,Sahl, H.G.,Deho, G.,Donadio, S.,Ebright, R.H.
Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase.
Cell, 169:1240-1248.e23, 2017
Cited by
PubMed Abstract: Drug-resistant bacterial pathogens pose an urgent public-health crisis. Here, we report the discovery, from microbial-extract screening, of a nucleoside-analog inhibitor that inhibits bacterial RNA polymerase (RNAP) and exhibits antibacterial activity against drug-resistant bacterial pathogens: pseudouridimycin (PUM). PUM is a natural product comprising a formamidinylated, N-hydroxylated Gly-Gln dipeptide conjugated to 6'-amino-pseudouridine. PUM potently and selectively inhibits bacterial RNAP in vitro, inhibits bacterial growth in culture, and clears infection in a mouse model of Streptococcus pyogenes peritonitis. PUM inhibits RNAP through a binding site on RNAP (the NTP addition site) and mechanism (competition with UTP for occupancy of the NTP addition site) that differ from those of the RNAP inhibitor and current antibacterial drug rifampin (Rif). PUM exhibits additive antibacterial activity when co-administered with Rif, exhibits no cross-resistance with Rif, and exhibits a spontaneous resistance rate an order-of-magnitude lower than that of Rif. PUM is a highly promising lead for antibacterial therapy.
PubMed: 28622509
DOI: 10.1016/j.cell.2017.05.042
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.323 Å)
構造検証レポート
Validation report summary of 5x21
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon